BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21745565)

  • 21. Cdc37 maintains cellular viability in Schizosaccharomyces pombe independently of interactions with heat-shock protein 90.
    Turnbull EL; Martin IV; Fantes PA
    FEBS J; 2005 Aug; 272(16):4129-40. PubMed ID: 16098195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3.
    Seyed M; Dimario JX
    J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
    Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L
    Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.
    Miyata Y; Nishida E
    Ann N Y Acad Sci; 2004 Dec; 1030():150-7. PubMed ID: 15659792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90.
    Zhao M; Ma J; Zhu HY; Zhang XH; Du ZY; Xu YJ; Yu XD
    Mol Cancer; 2011 Aug; 10():104. PubMed ID: 21871133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.
    Verma S; Singh A; Mishra A
    J Mol Graph Model; 2012 Jul; 37():27-38. PubMed ID: 22609743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation.
    Yun BG; Matts RL
    Cell Signal; 2005 Dec; 17(12):1477-85. PubMed ID: 15935620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hsp90 co-chaperones Cdc37 and Sti1 interact physically and genetically.
    Abbas-Terki T; Briand PA; Donzé O; Picard D
    Biol Chem; 2002 Sep; 383(9):1335-42. PubMed ID: 12437126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
    Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
    J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
    J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
    Keramisanou D; Aboalroub A; Zhang Z; Liu W; Marshall D; Diviney A; Larsen RW; Landgraf R; Gelis I
    Mol Cell; 2016 Apr; 62(2):260-271. PubMed ID: 27105117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.
    Vaughan CK; Mollapour M; Smith JR; Truman A; Hu B; Good VM; Panaretou B; Neckers L; Clarke PA; Workman P; Piper PW; Prodromou C; Pearl LH
    Mol Cell; 2008 Sep; 31(6):886-95. PubMed ID: 18922470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.
    Smith JR; Clarke PA; de Billy E; Workman P
    Oncogene; 2009 Jan; 28(2):157-69. PubMed ID: 18931700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloproliferative disorders: the centrosome connection.
    Delaval B; Lelièvre H; Birnbaum D
    Leukemia; 2005 Oct; 19(10):1739-44. PubMed ID: 16107884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
    Ren M; Qin H; Ren R; Tidwell J; Cowell JK
    Cancer Res; 2011 Dec; 71(23):7312-22. PubMed ID: 21937681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening.
    He J; Niu X; Hu C; Zhang H; Guo Y; Ge Y; Wang G; Jiang Y
    Protein Expr Purif; 2013 Nov; 92(1):119-27. PubMed ID: 24056254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion.
    El Hamidieh A; Grammatikakis N; Patsavoudi E
    PLoS One; 2012; 7(8):e42722. PubMed ID: 22912728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail.
    Gould CM; Kannan N; Taylor SS; Newton AC
    J Biol Chem; 2009 Feb; 284(8):4921-35. PubMed ID: 19091746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
    Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.